A 20-Minute Covid-19 Test Using Crispr Gene Editing Technology, Coming Soon To Your Doctor’s Office, Supermarket, And Workplace

Sherlock Biosciences is partnering with binx health to not only bring to market the first point-of-care Crispr product but also take the first step toward a new paradigm in health and diagnostics.

Bay Area COVID-Fighting Startup Files For $100m IPO

COVID-19 is a double whammy—killing over half a million people around the world and simultaneously derailing the global economy. Synthetic biology company Berkeley Lights is working out the antidote on both fronts.

Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approach

Many of today’s most trusted drugs are so notorious for their wide range of potentially serious adverse reactions, they are known in the business as “dirty drugs.” Synthetic biology company Octant Bio has developed a better way to design drugs for the most common and complex diseases like diabetes and heart disease. OCTANT BIO

previous arrow
next arrow
Slider

Featured

COVID-19 treatment prevention

COVID-19 Resources

SynBioBeta is proud to partner with Leaps by Bayer to make a visual timeline for COVID-19 treatment and prevention. The scientific community is working around the clock, not only to protect us from COVID-19, but to...

Editors' picks

Bay Area COVID-Fighting Startup Files For $100m IPO

COVID-19 is a double whammy—killing over half a million people around the world and simultaneously derailing the global economy. Synthetic biology company Berkeley Lights is working out the antidote on both fronts, fast...

Press releases

News by topic